Clinical Trial Update: Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers the use of carboplatin plus vinorelbine for stage IIIB or IV non-small cell lung cancer in Phase 1/Phase 2, with the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Navelbine (vinorelbine)

Snippet

Sponsor: Northwestern University | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED